Cue Biopharma

Cue Biopharma is a company listed under the stock ticker CUE (US).

View the org chart displaying its 10 main executives

Most searched biographies at Cue Biopharma

• Dan Passeri, Director, President and Chief Executive Officer
• Peter Kiener, Director
• Patrick Verheyen, Director

Create your alert
to follow the executive moves at Cue Biopharma.

Cue Biopharma has 1,861 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• MedMen has filed for bankruptcy protection  (posted on April 28 2024).
• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Lucia Aleotti - Director at Menarini Group
• Emma Walmsley - Chief Executive Officer and Director at GSK

Learn more about the Pharmaceuticals industry >

Press releases by Cue Biopharma

Social media about Cue Biopharma

• Cue Biopharma on Wikipedia, Google News & Yahoo Finance
• Cue Biopharma on LinkedIn, Twitter & YouTube

Contact by email its executives including Dan Passeri

Call Cue Biopharma at +1 61...

View the org chart

Register to receive your alert

Report an error